Friday, July 12, 3:00pm - 4:00pm (EDT)
Time zone
am/pm
24h
Suggestions
Your search did not return any results.
J. Silvio Gutkind, PhD, is a basic scientist with a passion for exploiting the emerging information on dysregulated signaling circuitries and individual genomic and molecular alterations to identify new therapeutic options to prevent and treat cancer. His lab's basic studies and translational efforts have already made an impact in the development of individualized, mechanism-based molecular-targeted (precision) anticancer treatments and immunotherapeutic strategies.
You're going to "STT Seminar | Novel Immunotherapy Targets: The Druggable Immune GPCRome and New Immune-Evasive Cancer Drivers".
We've sent a confirmation email to your email address. Be sure to check your junk folder in case you haven't received the confirmation.
You're interested in "STT Seminar | Novel Immunotherapy Targets: The Druggable Immune GPCRome and New Immune-Evasive Cancer Drivers".
We've sent a confirmation email to your email address. Be sure to check your junk folder in case you haven't received the confirmation.
Thank you!
Your changes have been saved. Thanks for keeping us updated.
Goldberg Auditorium and Zoom: https://uchealth.zoom.us/j/88306340802